- Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
- VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
- VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
- Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
- Volition appoints Dr Andrew Retter as Chief Medical Officer
More ▼
Key statistics
On Friday, VolitionRX Ltd (VNRX:ASQ) closed at 0.8909, 61.98% above the 52 week low of 0.55 set on Dec 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.8739 |
---|---|
High | 0.9149 |
Low | 0.845 |
Bid | 0.862 |
Offer | 0.95 |
Previous close | 0.8783 |
Average volume | 548.70k |
---|---|
Shares outstanding | 82.07m |
Free float | 62.44m |
P/E (TTM) | -- |
Market cap | 72.08m USD |
EPS (TTM) | -0.504 USD |
Data delayed at least 15 minutes, as of May 03 2024 21:10 BST.
More ▼